SH2db, an information system for the SH2 domain.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE

Publication: 1992- : Oxford : Oxford University Press
Original Publication: London, Information Retrieval ltd.

Information Systems* ; Proteins*/metabolism ; src Homology Domains*; Humans ; Amino Acid Sequence ; Binding Sites ; Phosphotyrosine/metabolism ; Protein Binding ; Internet ; Databases, Protein

SH2 domains are key mediators of phosphotyrosine-based signalling, and therapeutic targets for diverse, mostly oncological, disease indications. They have a highly conserved structure with a central beta sheet that divides the binding surface of the protein into two main pockets, responsible for phosphotyrosine binding (pY pocket) and substrate specificity (pY + 3 pocket). In recent years, structural databases have proven to be invaluable resources for the drug discovery community, as they contain highly relevant and up-to-date information on important protein classes. Here, we present SH2db, a comprehensive structural database and webserver for SH2 domain structures. To organize these protein structures efficiently, we introduce (i) a generic residue numbering scheme to enhance the comparability of different SH2 domains, (ii) a structure-based multiple sequence alignment of all 120 human wild-type SH2 domain sequences and their PDB and AlphaFold structures. The aligned sequences and structures can be searched, browsed and downloaded from the online interface of SH2db (http://sh2db.ttk.hu), with functions to conveniently prepare multiple structures into a Pymol session, and to export simple charts on the contents of the database. Our hope is that SH2db can assist researchers in their day-to-day work by becoming a one-stop shop for SH2 domain related research.
(© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.)

ACS Chem Biol. 2022 Jun 17;17(6):1472-1484. (PMID: 35613471)
Nature. 2021 Aug;596(7873):590-596. (PMID: 34293799)
Biochim Biophys Acta. 2005 Feb 14;1747(1):1-25. (PMID: 15680235)
Expert Opin Ther Targets. 2018 Jan;22(1):45-57. (PMID: 29148847)
Cancers (Basel). 2019 Nov 08;11(11):. (PMID: 31717342)
ACS Chem Biol. 2018 Mar 16;13(3):647-656. (PMID: 29304282)
J Med Chem. 2020 Nov 25;63(22):13578-13594. (PMID: 32910655)
Curr Opin Pharmacol. 2016 Oct;30:51-58. (PMID: 27475047)
Pharmacol Ther. 2022 Feb;230:107966. (PMID: 34403682)
Science. 1991 May 3;252(5006):668-74. (PMID: 1708916)
FEBS J. 2022 Oct;289(20):6235-6255. (PMID: 34235865)
Nat Struct Biol. 2003 Dec;10(12):980. (PMID: 14634627)
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9680-4. (PMID: 18599463)
Nat Commun. 2018 Oct 30;9(1):4508. (PMID: 30375388)
BMC Bioinformatics. 2004 Jun 22;5:79. (PMID: 15212693)
Adv Protein Chem. 2002;61:161-210. (PMID: 12461824)
Cancers (Basel). 2019 Dec 03;11(12):. (PMID: 31817042)
FEBS Lett. 2012 Aug 14;586(17):2597-605. (PMID: 22569091)
Structure. 1998 Mar 15;6(3):249-54. (PMID: 9551546)
J Mol Biol. 2003 Dec 5;334(4):823-41. (PMID: 14636606)
Anal Biochem. 2008 Apr 15;375(2):249-54. (PMID: 18258175)
Nucleic Acids Res. 2011 Jan;39(Database issue):D261-7. (PMID: 21062810)
Cell. 2010 Sep 3;142(5):661-7. (PMID: 20813250)
Trends Biochem Sci. 1995 Nov;20(11):470-5. (PMID: 8578591)
Nucleic Acids Res. 2023 Jan 6;51(D1):D395-D402. (PMID: 36395823)
Curr Opin Struct Biol. 2009 Dec;19(6):643-9. (PMID: 19926274)
Nucleic Acids Res. 2000 Jan 1;28(1):235-42. (PMID: 10592235)
Structure. 2022 Dec 1;30(12):1603-1614.e5. (PMID: 36417908)
Front Endocrinol (Lausanne). 2020 Sep 18;11:575220. (PMID: 33042028)
J Med Chem. 2004 Mar 25;47(7):1739-49. (PMID: 15027865)
J Biol Chem. 1995 Feb 17;270(7):2897-900. (PMID: 7531695)
Proteins. 2008 Aug;72(2):779-92. (PMID: 18260110)
Nature. 2021 Aug;596(7873):583-589. (PMID: 34265844)
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444. (PMID: 34791371)
J Med Chem. 2014 Jan 23;57(2):249-77. (PMID: 23941661)
Leukemia. 2018 Aug;32(8):1713-1726. (PMID: 29728695)
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296. (PMID: 33885785)
Nucleic Acids Res. 2018 Jan 4;46(D1):D440-D446. (PMID: 29155946)
J Med Chem. 2021 Nov 11;64(21):15973-15990. (PMID: 34714648)
J Phys Chem B. 2022 Nov 3;126(43):8689-8698. (PMID: 36281877)
Nucleic Acids Res. 2014 Jan;42(Database issue):D422-5. (PMID: 24304901)
Cell. 1998 Feb 20;92(4):441-50. (PMID: 9491886)
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):. (PMID: 34507989)
Int J Mol Sci. 2022 Dec 15;23(24):. (PMID: 36555586)
Nat Rev Cancer. 2004 Feb;4(2):97-105. (PMID: 14964307)
Nucleic Acids Res. 2021 Jan 8;49(D1):D562-D569. (PMID: 33084889)
Comput Struct Biotechnol J. 2021 Jun 16;19:3628-3639. (PMID: 34257841)
Nucleic Acids Res. 2003 Jul 1;31(13):3635-41. (PMID: 12824383)
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489. (PMID: 33237286)
Trends Cell Biol. 2001 Dec;11(12):504-11. (PMID: 11719057)
Mol Cell. 2006 Jun 23;22(6):851-868. (PMID: 16793553)
Protein Eng. 2003 Mar;16(3):217-27. (PMID: 12702802)
Trends Pharmacol Sci. 2015 Jan;36(1):22-31. (PMID: 25541108)
Blood. 2005 Sep 15;106(6):2183-5. (PMID: 15928039)
Mol Cell Proteomics. 2004 Jul;3(7):704-14. (PMID: 15073273)
J Med Chem. 2004 Mar 25;47(7):1750-9. (PMID: 15027866)
Leukemia. 2018 May;32(5):1135-1146. (PMID: 29472718)
Nat Commun. 2019 Jun 7;10(1):2517. (PMID: 31175292)

21820-51-9 (Phosphotyrosine)
0 (Proteins)

Date Created: 20230519 Date Completed: 20230712 Latest Revision: 20230718

20231215

PMC10320075

10.1093/nar/gkad420

37207333